The influence of prematurity and long chain polyunsaturate supplementation in 4-week adjusted age baboon neonate brain and related tissues.
Clinical studies show that docosahexaenoic acid (DHA) and arachidonic acid (ARA) supplemented formula improve visual function in preterm infants, however improved fatty acid status is known only for plasma and red blood cells (RBC) since target organs cannot be sampled from humans. Baboons were randomized to one of four groups: Term breast-fed (B); Term formula-fed (T-); Preterm formula-fed (P-); and Preterm DHA/ARA-supplemented formula-fed (P+). The P+ contained 0.61 +/- 0.03% DHA and 1.21 +/- 0.09% ARA, and breast milk had 0.68 +/- 0.22% and 0.62 +/- 0.12% as DHA and ARA, respectively. The B and P+ groups had significantly higher DHA concentration in all tissues than T- and P-. The P- group showed dramatically lower DHA content of 35%, 27%, 66%, and 75% in the brain, retina, liver, and plasma, respectively, compared with B. Supplementation prevented declines in DHA levels in the retina, and liver, and attenuated the decline in brain, plasma and RBC of preterm animals. In contrast, ARA was not significantly lower compared with B in any group in any tissue but was significantly elevated in liver and brain. RBC and plasma DHA were correlated with DHA in tissues; RBC/plasma ARA were uncorrelated with tissue ARA. We conclude that 1) DHA drops precipitously in term and preterm primates consuming formula without long chain polyunsaturates, while 22:5n-6 concentration rises; 2) tissue ARA levels are insensitive to dietary LCP supplementation or prematurity, 3) plasma and RBC levels of ARA are uncorrelated with total ARA levels; 4) DHA levels are correlated with group effects and are uncorrelated within groups.
Sarkadi-Nagy
Eszter
E
Cornell University, Savage Hall, Ithaca, NY 14853, USA.
Wijendran
Vasuki
V
Diau
Guan-Yeu
GY
Chao
Angela Chueh
AC
Hsieh
Andrea T
AT
Turpeinen
Anu
A
Nathanielsz
Peter W
PW
Brenna
J Thomas
JT
D000818:Animals; D000831:Animals, Newborn; D016718:Arachidonic Acid / Q000097:blood / Q000493:pharmacokinetics*; D004281:Docosahexaenoic Acids / Q000097:blood / Q000493:pharmacokinetics*; D004912:Erythrocytes / Q000378:metabolism; D005229:Fatty Acids, Monounsaturated / Q000378:metabolism; D005260:Female; D008099:Liver / Q000254:growth & development / Q000378:metabolism; D007752:Obstetric Labor, Premature; D010215:Papio; D011247:Pregnancy; D012044:Regression Analysis; D012160:Retina / Q000254:growth & development / Q000378:metabolism; D014793:Visual Cortex / Q000254:growth & development* / Q000378:metabolism
D005229:Fatty Acids, Monounsaturated; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid